Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
about
Atypical epithelial hyperplasia of the breast: state of the art.Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary settingLobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer RiskPrevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing.Effect of breast core needle biopsy technique on detection of lobular intraepithelial neoplasiaGenetic predisposition to in situ and invasive lobular carcinoma of the breast.Breast cancer medications and vision: effects of treatments for early-stage disease.Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.Breast cancer preoperative staging: does contrast-enhanced magnetic resonance mammography modify surgery?Non-operative breast pathology: lobular neoplasiaGenomics and premalignant breast lesions: clues to the development and progression of lobular breast cancerRisk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.Should the extent of lobular neoplasia on core biopsy influence the decision for excision?High-risk benign breast lesions: current strategies in management.Clonal relationships between lobular carcinoma in situ and other breast malignanciesIncidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy.Is there a role for routine screening MRI in women with LCIS?PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.Germline CDH1 mutations in bilateral lobular carcinoma in situ.Lobular neoplasia: morphology, biological potential and management in core biopsies.The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?Lobular breast cancer: pathology, biology, and options for clinical intervention.Current management of lesions associated with an increased risk of breast cancer.Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.Breast cancer in situ. From pre-malignant lesion of uncertain significance to well-defined non-invasive malignant lesion. The Danish Breast Cancer Cooperative Group Register 1977-2007 revisited.Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.Observation versus excision of lobular neoplasia on core needle biopsy of the breast.Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
P2860
Q30249199-6BF5ABD0-7AEF-4E76-A095-94EB4974642EQ33913513-37E6F33F-8B8A-42EC-A4D3-05DB88CE5E10Q34044916-6EA35944-5315-42E4-AE99-71B2DF15F588Q34421019-9610E61B-DE29-41F8-B14F-3139FAEBB6DDQ34986756-C439DE10-52A2-42E0-8D72-5BF592CD6FA1Q35151684-65EE33B6-8002-4782-BA36-D5800F7754A1Q35496778-C418B29C-CE0D-4DF8-A128-EE582ACA8CD8Q35596095-ECA51FA8-354B-4F10-92FD-891DB4D9E025Q35684492-BEC0FC63-6AE6-4EE4-B630-EF55077B692CQ36172476-00B681B8-6BF1-4CDF-8F43-1CD168CEFB48Q36465250-347870EC-9CA0-48DE-9E31-DBE0F36B56BEQ36615813-EFCA1BA1-9805-483A-8B4A-B7E0F457EBC9Q36703925-E703D1C1-CCB5-49D6-B022-90D2F9B7A4FAQ36959818-265FB229-7B69-4C08-B7ED-BFB0C5A9DCB3Q37031141-80552E9A-DC23-45EF-A211-E79C4953BB5EQ37174510-35799A74-57D3-4B38-A9A4-5479322CCB4BQ37240466-DE574E7D-0D92-4B39-BC96-F05A5965BD43Q37411839-3DC0BE8B-E755-4DFD-9857-E5AA3CEDE0A6Q37589094-72AB2BF7-FD63-4AB1-95CE-58CA1819DAA0Q37594356-C644DC77-0ADB-4CB5-B834-04241BF345E9Q37740943-C7AEA0D2-7BE9-4A1A-A812-F7CC6E4B6434Q37834472-E16FE048-4D00-438D-9FD3-0CBA1932E48DQ38130105-976A6556-077C-43C4-8050-59C2270ED951Q38333149-E32700B4-157E-4DEC-A4E8-EF487CDADC44Q38813328-2C7B8BF8-0D59-484F-9594-AB309790A26CQ40094258-BC06F930-C853-467C-9837-4717A762FC82Q41382046-3F1808A4-2B7D-440C-B74E-467F0A2DF5FCQ47211504-C30D07C9-C6D3-4492-BD9D-6350579A3CEEQ47323241-7B6A8636-3D4E-4AFB-9C4D-52F704254C94
P2860
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pathologic findings from the N ...... ing lobular carcinoma in situ.
@ast
Pathologic findings from the N ...... ing lobular carcinoma in situ.
@en
type
label
Pathologic findings from the N ...... ing lobular carcinoma in situ.
@ast
Pathologic findings from the N ...... ing lobular carcinoma in situ.
@en
prefLabel
Pathologic findings from the N ...... ing lobular carcinoma in situ.
@ast
Pathologic findings from the N ...... ing lobular carcinoma in situ.
@en
P2093
P356
P1433
P1476
Pathologic findings from the N ...... ing lobular carcinoma in situ.
@en
P2093
Bernard Fisher
Edwin R Fisher
Eleftherios Mamounas
Linda Gilarski
Norman Wolmark
Stephanie R Land
P2860
P304
P356
10.1002/CNCR.11883
P407
P577
2004-01-01T00:00:00Z